Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.554
https://www.valueinhealthjournal.com/article/S1098-3015(15)02630-3/fulltext
Title : Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02630-3&doi=10.1016/j.jval.2015.09.554
First page : A420
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 470
Categories :
Tags :
Regions :
ViH Article Tags :